JAZZ logo

Jazz Pharmaceuticals plc (JAZZ) Selling, general & administrative expenses

annual SGA:

$0.00-$1.34B(-100.00%)
December 31, 2024

Summary

  • As of today (September 1, 2025), JAZZ annual SGA is $0.00, with the most recent change of -$1.34 billion (-100.00%) on December 31, 2024.
  • During the last 3 years, JAZZ annual SGA has fallen by -$1.45 billion (-100.00%).
  • JAZZ annual SGA is now -100.00% below its all-time high of $1.45 billion, reached on December 31, 2021.

Performance

JAZZ SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

quarterly SGA:

$0.00-$514.01M(-100.00%)
June 30, 2025

Summary

  • As of today (September 1, 2025), JAZZ quarterly SGA is $0.00, with the most recent change of -$514.01 million (-100.00%) on June 30, 2025.
  • Over the past year, JAZZ quarterly SGA has dropped by -$338.52 million (-100.00%).
  • JAZZ quarterly SGA is now -100.00% below its all-time high of $514.01 million, reached on March 31, 2025.

Performance

JAZZ quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

TTM SGA:

$3.29B-$679.87M(-17.13%)
June 30, 2025

Summary

  • As of today (September 1, 2025), JAZZ TTM SGA is $3.29 billion, with the most recent change of -$679.87 million (-17.13%) on June 30, 2025.
  • Over the past year, JAZZ TTM SGA has increased by +$1.90 billion (+135.89%).
  • JAZZ TTM SGA is now -25.00% below its all-time high of $4.39 billion.

Performance

JAZZ TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherJAZZincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

JAZZ Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%+135.9%
3 y3 years-100.0%-100.0%+128.9%
5 y5 years-100.0%-100.0%+314.9%

JAZZ Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-100.0%at low-17.1%+1.8%
5 y5-year-100.0%at low-100.0%at low-25.0%+1.8%
alltimeall time-100.0%at low-100.0%at low-25.0%+260.8%

JAZZ Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$839.78M(-28.7%)
Mar 2025
-
$514.01M(>+9900.0%)
$1.18B(+16.0%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$1.02B(-28.0%)
Sep 2024
-
$325.77M(-3.8%)
$1.41B(+1.3%)
Jun 2024
-
$338.52M(-3.7%)
$1.39B(-0.2%)
Mar 2024
-
$351.71M(-11.2%)
$1.40B(+4.0%)
Dec 2023
$1.34B(-5.2%)
$396.03M(+28.5%)
$1.34B(+1.0%)
Sep 2023
-
$308.31M(-9.5%)
$1.33B(-3.6%)
Jun 2023
-
$340.84M(+14.4%)
$1.38B(-1.8%)
Mar 2023
-
$297.92M(-22.3%)
$1.41B(-0.8%)
Dec 2022
$1.42B(-2.4%)
$383.20M(+6.9%)
$1.42B(-1.1%)
Sep 2022
-
$358.48M(-2.2%)
$1.43B(-0.4%)
Jun 2022
-
$366.47M(+18.7%)
$1.44B(-4.2%)
Mar 2022
-
$308.81M(-22.5%)
$1.50B(+3.3%)
Dec 2021
$1.45B(+69.9%)
$398.46M(+9.6%)
$1.45B(+11.6%)
Sep 2021
-
$363.68M(-15.2%)
$1.30B(+13.7%)
Jun 2021
-
$429.03M(+64.7%)
$1.14B(+26.2%)
Mar 2021
-
$260.51M(+5.4%)
$906.34M(+6.1%)
Dec 2020
$854.23M(+15.9%)
$247.17M(+19.3%)
$854.23M(+4.0%)
Sep 2020
-
$207.25M(+8.3%)
$821.34M(+3.6%)
Jun 2020
-
$191.41M(-8.2%)
$792.79M(+2.0%)
Mar 2020
-
$208.40M(-2.7%)
$777.39M(+5.5%)
Dec 2019
$736.94M(+7.8%)
$214.28M(+19.9%)
$736.94M(+7.7%)
Sep 2019
-
$178.71M(+1.5%)
$684.53M(+3.5%)
Jun 2019
-
$176.01M(+4.8%)
$661.70M(+2.7%)
Mar 2019
-
$167.95M(+3.8%)
$644.26M(-5.7%)
Dec 2018
$683.53M(+25.6%)
$161.87M(+3.8%)
$683.53M(+2.8%)
Sep 2018
-
$155.87M(-1.7%)
$664.72M(+4.9%)
Jun 2018
-
$158.58M(-23.5%)
$633.37M(+4.3%)
Mar 2018
-
$207.21M(+44.9%)
$607.11M(+11.6%)
Dec 2017
$544.16M(+8.2%)
$143.05M(+14.9%)
$544.16M(+3.0%)
Sep 2017
-
$124.52M(-5.9%)
$528.25M(+0.0%)
Jun 2017
-
$132.33M(-8.3%)
$528.09M(+1.9%)
Mar 2017
-
$144.25M(+13.5%)
$518.38M(+3.1%)
Dec 2016
$502.89M(+12.0%)
$127.14M(+2.2%)
$502.89M(+0.3%)
Sep 2016
-
$124.37M(+1.4%)
$501.31M(+4.2%)
Jun 2016
-
$122.62M(-4.8%)
$480.98M(+3.3%)
Mar 2016
-
$128.76M(+2.6%)
$465.50M(+3.6%)
DateAnnualQuarterlyTTM
Dec 2015
$449.12M(+10.6%)
$125.56M(+20.7%)
$449.12M(+4.6%)
Sep 2015
-
$104.04M(-2.9%)
$429.26M(+2.5%)
Jun 2015
-
$107.13M(-4.7%)
$418.71M(+1.6%)
Mar 2015
-
$112.39M(+6.3%)
$412.14M(+1.5%)
Dec 2014
$406.11M(+33.5%)
$105.69M(+13.0%)
$406.11M(+6.4%)
Sep 2014
-
$93.50M(-7.0%)
$381.72M(+5.1%)
Jun 2014
-
$100.56M(-5.5%)
$363.19M(+6.8%)
Mar 2014
-
$106.36M(+30.8%)
$340.14M(+11.8%)
Dec 2013
$304.30M(+35.9%)
$81.30M(+8.4%)
$304.30M(+7.0%)
Sep 2013
-
$74.97M(-3.3%)
$284.38M(+5.2%)
Jun 2013
-
$77.51M(+9.9%)
$270.33M(+6.7%)
Mar 2013
-
$70.53M(+14.9%)
$253.47M(+10.2%)
Dec 2012
$223.88M(+105.5%)
$61.38M(+0.7%)
$229.94M(+12.2%)
Sep 2012
-
$60.92M(+0.5%)
$204.94M(+17.4%)
Jun 2012
-
$60.64M(+29.0%)
$174.57M(+28.3%)
Mar 2012
-
$47.00M(+29.2%)
$136.02M(+24.9%)
Dec 2011
$108.94M(+57.9%)
$36.38M(+19.1%)
$108.94M(+21.6%)
Sep 2011
-
$30.55M(+38.3%)
$89.62M(+16.2%)
Jun 2011
-
$22.09M(+11.0%)
$77.11M(+6.9%)
Mar 2011
-
$19.91M(+16.6%)
$72.12M(+4.5%)
Dec 2010
$69.00M(+17.6%)
$17.07M(-5.4%)
$69.00M(+2.0%)
Sep 2010
-
$18.04M(+5.5%)
$67.64M(+4.6%)
Jun 2010
-
$17.10M(+1.8%)
$64.67M(+5.6%)
Mar 2010
-
$16.79M(+6.8%)
$61.23M(+4.4%)
Dec 2009
$58.65M(-47.4%)
$15.72M(+4.4%)
$58.65M(-7.1%)
Sep 2009
-
$15.06M(+10.3%)
$63.12M(-12.8%)
Jun 2009
-
$13.66M(-3.9%)
$72.39M(-22.0%)
Mar 2009
-
$14.22M(-29.6%)
$92.84M(-16.7%)
Dec 2008
$111.40M(+41.8%)
$20.18M(-17.0%)
$111.40M(-6.5%)
Sep 2008
-
$24.33M(-28.7%)
$119.17M(+5.5%)
Jun 2008
-
$34.11M(+4.1%)
$112.92M(+16.4%)
Mar 2008
-
$32.78M(+17.3%)
$96.98M(+23.5%)
Dec 2007
$78.54M(+52.8%)
$27.96M(+54.7%)
$78.54M(+55.3%)
Sep 2007
-
$18.07M(-0.6%)
$50.58M(+55.6%)
Jun 2007
-
$18.18M(+26.8%)
$32.51M(+126.8%)
Mar 2007
-
$14.34M
$14.34M
Dec 2006
$51.38M(+118.2%)
-
-
Dec 2005
$23.55M(+215.7%)
-
-
Dec 2004
$7.46M
-
-

FAQ

  • What is Jazz Pharmaceuticals plc annual SGA?
  • What is the all time high annual SGA for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc annual SGA year-on-year change?
  • What is Jazz Pharmaceuticals plc quarterly SGA?
  • What is the all time high quarterly SGA for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc quarterly SGA year-on-year change?
  • What is Jazz Pharmaceuticals plc TTM SGA?
  • What is the all time high TTM SGA for Jazz Pharmaceuticals plc?
  • What is Jazz Pharmaceuticals plc TTM SGA year-on-year change?

What is Jazz Pharmaceuticals plc annual SGA?

The current annual SGA of JAZZ is $0.00

What is the all time high annual SGA for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high annual SGA is $1.45B

What is Jazz Pharmaceuticals plc annual SGA year-on-year change?

Over the past year, JAZZ annual SGA has changed by -$1.34B (-100.00%)

What is Jazz Pharmaceuticals plc quarterly SGA?

The current quarterly SGA of JAZZ is $0.00

What is the all time high quarterly SGA for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high quarterly SGA is $514.01M

What is Jazz Pharmaceuticals plc quarterly SGA year-on-year change?

Over the past year, JAZZ quarterly SGA has changed by -$338.52M (-100.00%)

What is Jazz Pharmaceuticals plc TTM SGA?

The current TTM SGA of JAZZ is $3.29B

What is the all time high TTM SGA for Jazz Pharmaceuticals plc?

Jazz Pharmaceuticals plc all-time high TTM SGA is $4.39B

What is Jazz Pharmaceuticals plc TTM SGA year-on-year change?

Over the past year, JAZZ TTM SGA has changed by +$1.90B (+135.89%)
On this page